Xuan Xiang

2.3k total citations
41 papers, 1.6k citations indexed

About

Xuan Xiang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xuan Xiang has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Xuan Xiang's work include Cancer Immunotherapy and Biomarkers (7 papers), Signaling Pathways in Disease (6 papers) and Cancer-related molecular mechanisms research (5 papers). Xuan Xiang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Signaling Pathways in Disease (6 papers) and Cancer-related molecular mechanisms research (5 papers). Xuan Xiang collaborates with scholars based in China, United States and Canada. Xuan Xiang's co-authors include Qiangsong Tong, Liduan Zheng, Kevin J. Murphy, Qiong Zhou, Jiarui Pu, Kai Huang, Xiao‐Shan Wei, Zi-Hao Wang, Hongxia Qu and Xiang Zhao and has published in prestigious journals such as Bioinformatics, PLoS ONE and Oncogene.

In The Last Decade

Xuan Xiang

37 papers receiving 1.6k citations

Peers

Xuan Xiang

IMMUN

NEURO

Ruth Wang United States

David Tuck United States

Jun Deng China

Patrick Flaherty United States

Fan Xia China

Haoyan Chen China

Weiwei Zhang China

Ji Young Park South Korea

Konstantinos Sidiropoulos United Kingdom

Ruth Wang United States

Xuan Xiang

753 ×0.9

207 ×0.3

443 ×1.6

86 ×0.3

IMMUN

110 ×0.5

NEURO

Citations per year, relative to Xuan Xiang Xuan Xiang (= 1×) peers Ruth Wang

Countries citing papers authored by Xuan Xiang

Since Specialization

Citations

This map shows the geographic impact of Xuan Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Xiang more than expected).

Fields of papers citing papers by Xuan Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Xiang. The network helps show where Xuan Xiang may publish in the future.

Co-authorship network of co-authors of Xuan Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan Xiang. A scholar is included among the top collaborators of Xuan Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan Xiang. Xuan Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Xiao‐Shan, Xuan Xiang, Haolei Wang, et al.. (2025). Tumor cell-intrinsic circular RNA circFNDC3B attenuates CD8+ T cells infiltration in non-small cell lung cancer. Communications Biology. 8(1). 711–711. 2 indexed citations

Ye, Linlin, Xuan Xiang, Zihao Wang, et al.. (2025). H3K18 lactylation in cancer-associated fibroblasts drives malignant pleural effusion progression via TNFR2+ Treg recruitment. Experimental & Molecular Medicine. 57(11). 2671–2685.

Gong, Zijian, et al.. (2025). Habitat analysis based on magnetic resonance imaging for the prediction of prostate cancer: a dual-center study. Quantitative Imaging in Medicine and Surgery. 15(9). 8395–8408.

Yang, Yifan, et al.. (2024). Research on Improved YOLOv7 for Traffic Obstacle Detection. World Electric Vehicle Journal. 16(1). 1–1. 1 indexed citations

Xue, Qianqian, Wenbei Peng, Siyu Zhang, et al.. (2023). Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing. Frontiers in Immunology. 14. 1148061–1148061. 8 indexed citations

Wei, Xiao‐Shan, et al.. (2023). Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity. Clinical & Translational Oncology. 25(8). 2306–2320. 20 indexed citations

Xiang, Xuan, Yiran Niu, Zi-Hao Wang, et al.. (2022). Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment. Cytokine & Growth Factor Reviews. 67. 35–48. 63 indexed citations

Wang, Zi-Hao, Pei Zhang, Yiheng Du, et al.. (2022). High-risk early-stage lung adenocarcinoma patients are identified by an immune-related circadian clock gene signature. Journal of Thoracic Disease. 14(10). 3748–3761. 2 indexed citations

Hu, Wei, et al.. (2022). HIV-child with disseminated Talaromyces Marneffei (Penicillium marneffei) infection: a rare severe case report. BMC Pediatrics. 22(1). 28–28. 3 indexed citations

10.

Xiang, Xuan, Zi-Hao Wang, Linlin Ye, et al.. (2021). Co-infection of SARS-COV-2 and Influenza A Virus: A Case Series and Fast Review. Current Medical Science. 41(1). 51–57. 28 indexed citations

11.

Zhou, Qiong, Virginia Chen, Casey P. Shannon, et al.. (2020). Interferon-α2b Treatment for COVID-19. Frontiers in Immunology. 11. 1061–1061. 274 indexed citations

12.

Ye, Linlin, Wenbei Peng, Yiran Niu, et al.. (2020). Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis. Annals of Translational Medicine. 8(24). 1647–1647. 25 indexed citations

13.

Zhao, Xiang, Dapeng Li, Jiarui Pu, et al.. (2015). CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression. Oncogene. 35(27). 3565–3576. 70 indexed citations

14.

Li, Dan, Hong Mei, Jiarui Pu, et al.. (2015). Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2. Molecular Cancer. 14(1). 47–47. 53 indexed citations

15.

Xiang, Xuan, Hong Mei, Hongxia Qu, et al.. (2015). miRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(9). 1743–1754. 49 indexed citations

16.

Qu, Hongxia, Liduan Zheng, Jiarui Pu, et al.. (2015). miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase. Human Molecular Genetics. 24(9). 2539–2551. 83 indexed citations

17.

Xiang, Xuan, Xiang Zhao, Hongxia Qu, et al.. (2015). Hepatocyte nuclear factor 4 alpha promotes the invasion, metastasis and angiogenesis of neuroblastoma cells via targeting matrix metalloproteinase 14. Cancer Letters. 359(2). 187–197. 36 indexed citations

18.

Zheng, Xiaodan, Dan Li, Dehua Yang, et al.. (2014). Association of Ureaplasma urealyticum colonization with development of bronchopulmonary dysplasia: A systemic review and meta-analysis. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(2). 265–269. 7 indexed citations

19.

Zheng, Liduan, Dan Li, Xuan Xiang, et al.. (2013). Methyl jasmonate abolishes the migration, invasion and angiogenesis of gastric cancer cells through down-regulation of matrix metalloproteinase 14. BMC Cancer. 13(1). 74–74. 46 indexed citations

20.

Zheng, Liduan, Jiarui Pu, Teng Fei Qi, et al.. (2012). miRNA-145 Targets v-ets Erythroblastosis Virus E26 Oncogene Homolog 1 to Suppress the Invasion, Metastasis, and Angiogenesis of Gastric Cancer Cells. Molecular Cancer Research. 11(2). 182–193. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact